Trial Profile
Multi-Center, Randomized, Single Masked Phase 2 Study of Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 May 2019
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Lidocaine
- Indications Age-related macular degeneration; Dry macular degeneration
- Focus Therapeutic Use
- 24 Apr 2015 New trial record